New Alternative Anticoagulants in Atrial Fibrillation: The Move Beyond Warfarin.

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|8|2|78-85

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.8, Iss.2, 2013-01, pp. : 78-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Anticoagulants vs Warfarin for Stroke Prevention in Atrial Fibrillation

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 14, Iss. 1, 2014-03 ,pp. : 79-86

Bentham Science Publishers

Access to resources Recommend Favorite

Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

By  

Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. : 6096-6105

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond heparin and warfarin: the new generation of anticoagulants

By Weitz Jeffrey I   Linkins Lori-Ann  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 271-282

Informa Healthcare

Access to resources Recommend Favorite

Warfarin use suboptimal in new-onset atrial fibrillation

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 427, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation

By  

JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (ELECTRONIC), Vol. 27, Iss. 4, 2015-04 ,pp. : 190-196

John Wiley & Sons Inc

Access to resources Recommend Favorite